Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.
about
T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) speciesFirst-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimonyAsymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studiesY chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan.Prediction score for antimony treatment failure in patients with ulcerative leishmaniasis lesions.IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infectionPrevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia.Evidence for a major gene controlling susceptibility to tegumentary leishmaniasis in a recently exposed Bolivian population.Human genetic susceptibility and infection with Leishmania peruviana.Parasitological Confirmation and Analysis of Leishmania Diversity in Asymptomatic and Subclinical Infection following Resolution of Cutaneous Leishmaniasis.Gene Expression Profile of High IFN-γ Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous LeishmaniasisEndemic transmission of visceral leishmaniasis in BhutanClinical cutaneous leishmaniasis rates are associated with household Lutzomyia gomezi, Lu. Panamensis, and Lu. trapidoi abundance in Trinidad de Las Minas, western Panama.Leishmaniasis sand fly vector density reduction is less marked in destitute housing after insecticide thermal fogging.Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments.Characterization of regulatory T cell (Treg) function in patients infected with Leishmania braziliensis.Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis.Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.Natural infections of Leishmania peruviana in animals in the Peruvian Andes.Domestic dog ownership: a risk factor for human infection with Leishmania (Viannia) species.Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia.Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil.Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort StudyGenome-wide scan for visceral leishmaniasis susceptibility genes in Brazil.Involvement of different CD4(+) T cell subsets producing granzyme B in the immune response to Leishmania major antigens.Genetic epidemiology of visceral leishmaniasis in northeastern Brazil.The role of IL15 gene variants in visceral leishmaniasis among Iranian patients.An overview of skin lesions adapted to Cutaneous Leishmaniasis in Persian Medicine.Climate and recruitment limitation of hosts: the dynamics of American cutaneous leishmaniasis seen through semi-mechanistic seasonal models.Parasite, vectors and reservoirs as determinants of tegumentary leishmaniasis.IFN-γ Response Is Associated to Time Exposure Among Asymptomatic Immune Responders That Visited American Tegumentary Leishmaniasis Endemic Areas in Peru
P2860
Q24336673-93CA46C3-74D2-4582-B4BA-D391C46BE66CQ28475794-19DDC912-9335-42F5-84FA-37284BF60381Q30244323-908FF3E6-76F5-47AC-9E7E-B8B26D8091E9Q33284534-7815E8EF-716E-4128-8CD3-0E07ADE8A683Q34312381-0C961D5E-4CD4-4410-8B54-FBE33EE0DDC2Q34535297-2E6394C9-42F2-4740-B35C-219E9CC069C0Q34672414-90D2FD47-642F-4694-8CE2-0B16E8D03B77Q35249747-CE0269AF-90F1-4193-A9F7-9D2C7BF6EDFBQ35644020-72C8B719-1CB1-4446-8E30-5CED6CEE659FQ35867155-A82B67AD-160C-48D5-BCD8-C7FA02AD8761Q36199662-09BA5093-3467-4F87-A4CD-05A56FEB3A6BQ36450105-0BED111F-EB9B-4A5F-84D5-F33E47F8893BQ36669157-6B2DA3FD-9531-42CD-8396-19122A283E26Q36958279-EB302086-4C5E-469C-A211-F9E046DBEC65Q36970088-5D1D518E-A94F-499A-A060-9BEB598E4E93Q37355885-21C301FB-1A4F-4868-8C06-2D1AA20FEAE6Q38963284-BE0553FA-EE6E-4C82-99E3-1AB46A61453DQ39185984-5DD0322E-69AC-497E-96EB-ECD116DE5C49Q39186002-5FF10091-B229-4235-BD67-0122EFC0FCFEQ39391808-B4284483-851E-40DC-91B3-6F7989E4161EQ39432514-7F4800BB-B63E-4CAA-8114-8D9DE428AFFDQ39530162-26348842-126C-4683-ACA8-0D12F226AF91Q40670558-C6CECF34-B9CD-4152-A8F1-1F88E36EB762Q41259097-0AF9D388-3C50-4EBF-AF32-EDDD6A0059D1Q41856326-7427B0DD-D4E0-49E9-81C9-73B19F04B03BQ44605945-CE114039-212C-4A46-BBDA-A1715C36D47DQ45045228-419664EC-9B3F-44D0-AB76-42276E5017A7Q49876091-A2C83A3B-4173-4527-812A-AC2D908AA546Q51664156-4E28761B-13F5-4C45-9B47-B4DA22A7AD68Q52742705-05D4AC58-0644-449F-953A-466B7B914C5AQ58728289-4D36BBE9-4FAF-4ED1-B83B-FABC826EC800
P2860
Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@ast
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@en
type
label
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@ast
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@en
prefLabel
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@ast
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@en
P2093
P2860
P1476
Cutaneous leishmaniasis in the ...... udy of infection and immunity.
@en
P2093
C R Davies
E A Llanos-Cuentas
P2860
P304
P356
10.1017/S0950268800057964
P577
1995-04-01T00:00:00Z